Neuroinflammation and comorbidities are frequently ignored factors in CNS pathology

Neural Regeneration Research

Volumn 10, Issue 9, 2015, Pages 1349-1355

  Sandu, Raluca Elena ^b   Buga, Ana Maria ^a,b   Uzoni, Adriana ^a,c   Petcu, Eugen Bogdan ^d   Popa Wagner, Aurel ^a,b  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^b UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^c VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d GRIFFITH UNIVERSITY   (Australia)

Author keywords

Aging; Comorbidities; Dementia; Depression; Neuroinflammation; Stroke

Indexed keywords

AGING; ARTICLE; ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; CHRONIC INFLAMMATION; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; MULTIINFARCT DEMENTIA; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OBESITY; PATHOLOGY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84942083410     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.4103/1673-5374.165208     Document Type: Article

References (98)

1. Alexopoulos GS (2006) The vascular depression hypothesis: 10 years later. Biol Psychiatry 60:1304-1305.
2. Allison DJ, Ditor DS (2014) The common inflammatory etiology of depression and cognitive impairment: a therapeutic target. J Neuroinflammation 11:151.
3. Andersen KK, Olsen TS (2013) Body mass index and stroke: overweight and obesity less often associated with stroke recurrence. J Stroke Cerebrovasc Dis 2:26.
4. Anisman H, Merali Z, Hayley S (2008) Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Prog Neurobiol 85:1-74.
5. Badan I, Buchhold B, Hamm A, Gratz M, Walker LC, Plattparallel D, Kessler Ch, Popa-Wagner A (2003) Accelerated glial reactivity to stroke in aged rats correlates with reduced functional recovery. J Cereb Blood Flow Metab 23:845-854.
6. Bauer LO (2008) Psychiatric and neurophysiological predictors of obesity in HIV/AIDS. Psychophysiology 45:1055-1063.
7. Baune BT, Smith E, Reppermund S, Air T, Samaras K, Lux O, Brodaty H, Sachdev P, Trollor JN (2012) Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: the prospective Sydney Memory and Aging Study. Psychoneuroendocrinology 37:1521-1530.
8. Bictash M, Ebbels TM, Chan Q, Loo RL, Yap IK, Brown IJ, de Iorio M, Daviglus ML, Holmes E, Stamler J, Nicholson JK, Elliott P (2010) Opening up the “Black Box”: metabolic phenotyping and metabolome-wide association studies in epidemiology. J Clin Epidemiol 63:970-979.
9. Bonita R, Beaglehole R (1988) Recovery of motor function after stroke. Stroke 19:1497-1500.
10. Bremmer MA, Beekman A, Deeg DJ, Penninx BW, Dik MG, Hack CE, Hoogendijk WJ (2008) Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord 106:249-255.
11. Bruunsgaard H, Pedersen M, Pedersen BK (2001) Aging and proinflammatory cytokines. Curr Opin Hematol 8:131-136.
12. Buchhold B, Mogoanta L, Suofu Y, Hamm A, Walker L, Kessler Ch, Popa-Wagner A (2007) Environmental enrichment improves functional and neuropathological indices following stroke in young and aged rats. Restor Neurol Neurosci 25:467-484.
13. Buga AM, Di Napoli M, Popa-Wagner A (2013) Preclinical models of stroke in aged animals with or without comorbidities: role of neuroinflammation. Biogerontology 14:651-662.
14. Buga AM, Scholz CJ, Kumar S, Herndon J, Alexandru D, Cojocaru GR, Dandekar T, Popa-Wagner A (2012) Identification of new therapeutic targets by genome-wide analysis of gene expression in the ipsilateral cortex of aged rats after stroke. PLoS One 7:e50985.
15. Burke DT, Al-Adawi S (2014) Effect of body mass index on stroke rehabilitation. J Stroke Cerebrovasc Dis 95:1055-1059.
16. Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C (1994) Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project. Stroke 25:333-337.
17. Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C, Coupaye M, Pelloux V, Hugol D, Bouillot JL, Bouloumie A, Barbatelli G, Cinti S, Svensson PA, Barsh GS, Zucker JD, Basdevant A, Langin D, Clement K (2005) Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54:2277-2286.
18. Capuron L, Miller AH (2011) Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 130:226-238.
19. Capuron L, Poitou C, Machaux-Tholliez D, Frochot V, Bouillot JL, Basdevant A, Laye S, Clement K (2010) Relationship between adiposity, emotional status and eating behaviour in obese women: role of inflammation. Psychol Med 41:1517-1528.
20. Capuron L, Su S, Miller AH, Bremner JD, Goldberg J, Vogt GJ, MAisano C, Jones L, Murrah NV, Vaccarino V (2008) Depressive symptoms and metabolic syndrome: is inflammation the underlying link? Biol Psychiatry 64:896-900.
21. Caraci F, Copani A, Nicoletti F, Drago F (2010) Depression and Alzheimer’s disease: neurobiological links and common pharmacological targets. Eur J Pharmacol 626:64-71.
22. Cornelis MC, Hu FB (2012) Gene-environment interactions in the development of type 2 diabetes: recent progress and continuing challenges. Annu Rev Nutr 32:245-259.
23. Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Rev Neurosci 9:46-56.
24. de Leeuw FE, de Groot JC, Oudkerk M, Witteman JC, Hofman A, van Gijn J, Breteler MM (2002) Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 125:765-772.
25. Di Napoli M, Godoy DA, Campi V, Masotti L, Smith CJ, Parry-Jones AR, Hopkins SJ, Slevin M, Papa F, Mogoanta L, Pirici D, Popa-Wagner A (2012) C-reactive protein in intracerebral hemorrhage: time course, tissue localization, and prognosis. Neurology 79:690-699.
26. Di Napoli M, Parry-Jones AR, Smith CJ, Hopkins SJ, Slevin M, Masotti L, Campi V, Singh P, Papa F, Popa-Wagner A, Tudorica V, Godoy DA (2014) C-reactive protein predicts hematoma growth in intracerebral hemorrhage. Stroke 45:59-65.
27. Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KR, Nemeroff CB, Bremner JD, Carney RM, Coyne JC, Delong MR, Frasure-Smith N, Glassman AH, Gold PW, Grant I, Gwyther L, Ironson G, Johnson RL, Kanner AM, Katon WJ, et al. (2005) Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 58:175-189.
28. Fagiolo U, Cossarizza A, Santacaterina S, Ortolani C, Monti D, Paganelli R, Franceschi C (1992) Increased cytokine production by peripheral blood mononuclear cells from healthy elderly people. Ann N Y Acad Sci 663:490-493.
29. Fagiolo U, Cossarizza A, Scala E, Fanales-Belasio E, Ortolani C, Cozzi E Monti D, Franceschi C, Paganelli R (1993) Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 23:2375-2378.
30. Fenn AM, Gensel JC, Huang Y, Popovich PG, Lifshitz J, Godbout JP (2013) Immune activation promotes depression 1 month after diffuse brain injury: a role for primed microglia. Biol Psychiatry 76:575-584.
31. Ghiadoni L, Virdis A, Magagna A, Taddei S, Salvetti A (2000) Effect of the angiotensin II type 1 receptor blocker candesartan on endothelialfunction in patients with essential hypertension. Hypertension 35:501-506.
32. Gildengers AG, Whyte EM, Drayer RA, Soreca I, Fagiolini A, Kilbourne AM, Houck PR, Reynolds CF, Frank E, Kupfer DJ, Mulsant BH (2008) Medical burden in late-life bipolar and major depressive disorders.Am J Geriatr Psychiatry 16:194-200.
33. Goossens GH (2008) The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav 94:206-218.
34. Goossens GH, Bizzarri A, Venteclef N, Essers Y, Cleutjens JP, Konings E, Jocken JW, Cajlakovic M, Ribitsch V, Clément K, Blaak EE (2011) Increased adipose tissue oxygen tension in obese compared with leanmen is accompanied by insulin resistance, impaired adipose tissue capillarization, and inflammation. Circulation 124:67-76.
35. Hackett ML, Anderson CS (2005) Predictors of depression after stroke: a systematic review of observational studies. Stroke 36:2296-2301.
36. Hanisch UK, Kettenmann H (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10:1387-1394.
37. Howcroft TK, Campisi J, Louis GB, Smith MT, Wise B, Wyss-Coray T, Augustine AD, McElhaney JE, Kohanski R, Sierra F (2013) Aging 5:84-93.
38. Illig T, Gieger C, Zhai G, Römisch-Margl WA, Wang-Sattler R, Prehn C, Altmaier E, Kastenmüller G, Kato BS, Mewes HW, Meitinger T, de Angelis MH, Kronenberg F, Soranzo N, Wichmann HE, Spector TD, Adamski J, Suhre K (2010) A genome-wide perspective of geneticvariation in human metabolism. Nat Genet 42:137-141.
39. Jeste DV, Palmer BW (2013) A call for a new positive psychiatry of ageing. Br J Psychiatry 202:81-83.
40. Kabon B, Nagele A, Reddy D, Eagon C, Fleshman JW, Sessler DI, Kurz A (2004) Obesity decreases perioperative tissue oxygenation. Anesthesiology 100:274-280.
41. Kekow J, Moots RJ, Emery P, Durez P, Koenig A, Singh A, Pedersen R, Robertson D, Freundlich B, Sato R (2010) Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial. Ann Rheum Dis 69: 222-225.
42. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Life time prevalence and age-of-onset distributions of DSMIV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:593-602.
43. Kettunen J, Tukiainen T, Sarin AP, Ortega-Alonso A, Tikkanen E, Lyytikäinen LP, Kangas AJ, Soininen P, Würtz P, Silander K, Dick DM, Rose RJ, Savolainen MJ, Viikari J, Kähönen M, Lehtimäki T, Pietiläinen KH, Inouye M, McCarthy MI, Jula A, et al. (2012) Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet 44:269-276.
44. Knol MJ, Twisk JW, Beekman AT, Heine RJ, Snoek FJ, Pouwer F (2006) Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 49:837-845.
45. Krishnadas R, Cavanagh J (2012) Depression: an inflammatory illness? J Neurol Neurosurg Psychiatry 83:495-502.
46. Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H (2000) Cytokineproduction and treatment response in major depressive disorder. Neuropsychopharmacology 22:370-379.
47. Lindner MD, Gribkoff VK, Donlan NA, Jones TA (2003) Long-lastingfunctional disabilities in middle-aged rats with small cerebral infarcts.J Neurosci 23:10913-10922.
48. Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, Powell C, Vedantam S, Buchkovich ML, Yang J, Croteau-Chonka DC, Esko T, Fall T, Ferreira T, Gustafsson S, Kutalik Z, Luan J, Mägi R, Randall JC, Winkler TW, et al. (2015) Genetic studies of body mass index yield new insights for obesity biology. Nature 518:197-206.
49. Maes M (2011) Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry 35:664-675.
50. Manwani B, Liu F, Xu Y, Persky R, Li J, McCullough LD (2011) Functional recovery in aging mice after experimental stroke. Brain Behav Immun 25:1689-1700.
51. McIntyre RS, Soczynska JK, Konarski JZ, Woldeyohannes HO, Law CW, Miranda A, Fulgosi D, Kennedy SH (2007) Should depressive syndromes be reclassified as “metabolic syndrome type II”? Ann ClinPsychiatry 19:257-264.
52. Milaneschi Y, Corsi AM, Penninx BW, Bandinelli S, Guralnik JM, Ferrucci L (2009) Interleukin-1 receptor antagonist and incident depressive symptoms over 6 years in older persons: the InCHIANTI study. Biol Psychiatry 65:973-978.
53. Miller AH, Maletic V, Raison CL (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65:732-741.
54. Molino-Lova R, Macchi C, Gori AM, Marcucci R, Polcaro P, Cecchi F, Lauretani F, Bandinelli S, Abbate R, Beghi E, Guralnik JM, Ferrucci L (2011) High sensitivity C-reactive protein predicts the development of new carotid artery plaques in older persons. Nutr Metab Cardiovasc Dis 21:776-782.
55. Murray KN, Buggey HF, Denes A, Allan SM (2013) Systemic immuneactivation shapes stroke outcome. Mol Cell Neurosci 53:14-25.
56. Nagata R, Kawabe K, Ikeda K (2010) Olmesartan an angiotensin II receptor blocker, restores cerebral hypoperfusion in elderly patients with hypertension. J Stroke Cerebrovasc Dis 19:236-240.
57. Najjar S, Pearlman DM, Devinsky O, Najjar A, Zagzag D (2013) Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. J Neuroinflammation 10:142.
58. Nemeroff CB (2003) The role of GABA in the pathophysiology and treatment of anxiety disorders. Psychopharmacol Bull 37:133-146.
59. Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314-1318.
60. Olsen TS, Dehlendorff C, Petersen HG, Andersen KK (2008) Body mass index and poststroke mortality. Neuroepidemiology 30:93-100.
61. Ovbiagele B, Bath PM, Cotton D, Vinisko R, Diener HC (2011) Obesity and recurrent vascular risk after a recent ischemic stroke. Stroke 42:3397-3402.
62. Papakostas GI, Shelton RC, Kinrys G, Henry ME, Bakow BR, Lipkin SH, Pi B, Thurmond L, Bilello JA (2013) Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a Pilot and Replication Study. Mol Psychiatry 18:332-339.
63. Pasarica M, Sereda OR, Redman LM, Albarado DC, Hymel DT, Roan LE, Rood JC, Burk DH, Smith SR (2009) Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes 58:718-725.
64. Penninx BW, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S, Rubin S, Ferrucci L, Harris T, Pahor M (2003) Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study. Biol Psychiatry 54:566-572.
65. Petcu EB, Smith RA, Miroiu RI, Opris MM (2010) Angiogenesis in oldaged subjects after ischemic stroke: a cautionary note for investigators. J Angiogenes Res 2:26.
66. Popa-Wagner A, Buga AM, Kokaia Z (2011) Perturbed cellular response to brain injury during aging. Ageing Res Rev 10:71-79.
67. Popa-Wagner A, Buga AM, Tica AA, Albu CV (2014) Perfusion deficits, inflammation and aging precipitate depressive behaviour. Biogerontology 15:439-448.
68. Poulsen Olefsky JM, Glass CK (2010) Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72:219-246.
69. Poulsen P, Kyvik KO, Vaag A, Beck-Nielsen H (1999) Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance-a population-based twin study. Diabetologia 42:132-145.
70. Raison CL, Rutherford RD, Woolwine BJ, Shuo C, Schettler P, Drake DF, Haroon E, Miller AH (2012) A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. Arch Gen Psychiatry 3:1-11.
71. Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, Haroon E, Miller AH (2013) A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 70:31-41.
72. Rausch ME, Weisberg S, Vardhana P, Tortoriello DV (2008) Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration. Int J Obes (Lond) 32:451-463.
73. Rizzo M, Corrado E, Coppola G, Muratori I, Mezzani A Novo G, Novo S (2009) The predictive role of C-reactive protein in patients with hypertension and subclinical atherosclerosis. Coron Artery Dis 20:15-20.
74. Rizzo M, Corrado E, Coppola G, Muratori I, Novo G, Novo S (2009) Markers of inflammation are strong predictors of subclinical and clinical atherosclerosis in women with hypertension. Intern Med J 39:539-545.
75. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, et al. (2012) Executive summary: heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 125:188-197.
76. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 163:1905-1917.
77. Ryu WS, Lee SH, Kim CK, Yoon BW (2011) Body mass index, initial neurological severity and long-term mortality in ischemic stroke. Cerebrovasc Dis 32:170-176.
78. Schiffrin EL (2014) Inflammation, immunity and development of essential hypertension. J Hypertens 32:228-229.
79. Shimizu M, Ishikawa J, Yano Y, Hoshide S, Shimada K, Kario K (2011) The relationship between the morning blood pressure surge and low-grade inflammation on silent cerebral infarct and clinical stroke events. Atherosclerosis 219:316-321.
80. Shimizu K, Shimomura K, Tokuyama Y, Sakurai K, Isahaya K, Takaishi S, Kato B, Usuki N, Shimizu T, Yamada K, Hasegawa Y (2013) Association between inflammatory biomarkers and progression of intracranial large artery stenosis after ischemic stroke. J Stroke Cerebrovasc Dis 22:211-217.
81. Shungin D, Winkler TW, Croteau-Chonka DC, Ferreira T, Locke AE, Mägi R, Strawbridge RJ, Pers TH, Fischer K, Justice AE, Workalemahu T, Wu JM, Buchkovich ML, Heard-Costa NL, Roman TS, Drong AW, Song C, Gustafsson S, Day FR, Esko T, et al. (2015) New genetic loci link adipose and insulin biology to body fat distribution. Nature 518:187-196.
82. Sluzewska A, Sobieska M, Rybakowski JK (1997) Changes in acutephase proteins during lithium potentiation of antidepressants in refractory depression. Neuropsychobiology 35:123-127.
83. Suhre K, Shin SY, Petersen AK, Mohney RP, Meredith D, Wägele B, Altmaier E; Cardiogram, Deloukas P, Erdmann J, Grundberg E, Hammond CJ, de Angelis MH, Kastenmüller G, Köttgen A, Kronenberg F, Mangino M, Meisinger C, Meitinger T, Mewes HW, et al. (2011) Human metabolic individuality in biomedical and pharmaceutical research. Nature 477:54-60.
84. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, Ripatti S, Chasman DI, Willer CJ, Johansen CT, Fouchier SW, Isaacs A, Peloso GM, Barbalic M, Ricketts SL, Bis JC, Aulchenko YS, Thorleifsson G, Feitosa MF, et al. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466:707-713.
85. Tiemeier H, Breteler MM, van Popele NM, Hofman A, Witteman JC (2003) Late-life depression is associated with arterial stiffness: a population- based study. J Am Geriatr Soc 51:1105-1110.
86. Tousoulis D, Kampoli AM, Papageorgiou N, Androulakis E, Antoniades C, Toutouzas K, Stefanadis C (2011) Pathophysiology of atherosclerosis: the role of inflammation. Curr Pharm Des 17:4089-4110.
87. Towfighi A, Ovbiagele B (2009) The impact of body mass index on mortality after stroke. Stroke 40:2704-2708.
88. Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, Lalla D, Woolley M, Jahreis A, Zitnik R, Cella D, Krishnan R (2006) Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebocontrolled randomised phase III trial. Lancet 367:29-35.
89. van den Biggelaar AH, Gussekloo J, de Craen AJ, Frölich M, Stek ML, van der Mast RC, Westendorp RG (2007) Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Exp Gerontol 42:693-701.
90. Vemmos K, Ntaios G, Spengos K, Savvari P, Vemmou A, Pappa T, Manios E, Georgiopoulos G, Alevizaki M (2011) Association between obesity and mortality after acute first-ever stroke: the obesity-stroke paradox. Stroke 42:30-36.
91. Wakselman S, Bechade C, Roumier A, Bernard D, Triller A, Bessis A (2008) Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor. J Neurosci 28:8138-8143.
92. Willey JZ, Ortega-Gutierrez S, Petersen N, Khatri P, Ford AL, Rost NS, Ali LK, Gonzales NR, Merino JG, Meyer BC, Marshall RS (2012) Impact of acute ischemic stroke treatment in patients >80 years of age: the specialized program of translational research in acute stroke (SPOTRIAS) consortium experience. Stroke 43:2369-2375.
93. Wolkowitz OM, Epel ES, Reus VI, Mellon SH (2010) Depress Anxiety Depression gets old fast: do stress and depression accelerate cell aging? Depress Anxiety 27:327-338.
94. Ye J, Gao Z, Yin J, He Q (2007) Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 293:E1118-1128.
95. Ye SM, Johnson RW (1999) Increased interleukin-6 expression by microglia from brain of aged mice. J Neuroimmunol 93:139-148.
96. Zhao L, Du W, Zhao X, Liu L, Wang C, Wang Y, Xu Y (2014) Favorable functional recovery in overweight ischemic stroke survivors: findings from the China National Stroke Registry. J Stroke Cerebrovasc Dis 23:e201-206.
97. Zuliani G, Guerra G, Ranzini M, Rossi L, Munari MR, Zurlo A, Blè A, Volpato S, Atti AR, Fellin R (2007) High interleukin-6 plasma levels are associated with functional impairment in older patients with vascular dementia. Int J Geriatr Psychiatry 22:305-311.
98. Zunszain PA, Hepgul N, Pariante CM (2013) Inflammation and depression. Curr Topics Behav Neurosci 14:135-151.